Skip to main content
Clinical Trials/CTRI/2020/10/028187
CTRI/2020/10/028187
Not yet recruiting
Phase 2

A RANDOMIZED,CONTROLLED,CLINICAL STUDY OF EFFICACY OF LOCAL APPLICATION OF TILASHTAK GHRITA IN MANAGEMENT OF DUSHTA AVASTHA OF VRANA WITH SPECIAL REFERENCE TO INFECTED WOUND.

Meera Nagre0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Sponsor
Meera Nagre
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Meera Nagre

Eligibility Criteria

Inclusion Criteria

  • Wound length 3 to 15 cm
  • Patients with fulfilled screening criteria
  • Wounds up to muscle

Exclusion Criteria

  • Patients suffering from major illness like cirrhosis liver disorder or Ascitis or Renal Failure or DM or Tuberculosis or AIDS or HIV syndrome
  • Patient with malignancy
  • Bleeding Disorder
  • Multiple Ulcer(more than three)
  • Arterial Ulcers
  • Leprotic ulcers
  • Gonorrheal ulcers
  • Syphilitic ulcers
  • Vranas situated over Asthi and Sandhi and Koshta and Marma Adhisthana
  • Age Group \<18year and \>60 years old

Outcomes

Primary Outcomes

Not specified

Similar Trials